Search

everythinglearnresearchcommunity

for

Search:↓

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Acne vulgaris is a common skin condition that can cause low self-esteem and depression, and early treatment is important to prevent scarring.

The Rotterdam Study investigates diseases in older adults and has produced many research findings.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

Blocking interferon-gamma might help treat various autoimmune diseases.

Flavonoids in Iraqi marshland plants have potential health benefits like antioxidant and anti-inflammatory effects.

SSAT is a key enzyme affecting cell growth and metabolism, with potential but risky use in disease treatment.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

The convention highlighted the importance of comprehensive patient care and early diagnosis in dermatology.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Hemp is a promising ingredient for skin products due to its healing and soothing properties.

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Blue light therapy is promising for skin and hair conditions but needs more research for widespread use.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Transethosomes improve drug delivery through the skin by overcoming the outer skin layer's barrier.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.